Managers
Private equity firm MidOcean Partners has acquired, along with Vulcan Capital and other investors, Water Pik, a marketer and supplier of branded health and wellness products.
Water Pik has become the market leader in both its oral health and replacement showerhead business segments. Water Pik’s oral health business offers a complete line of products, including its line of water flossers, a clinically proven sonic toothbrush and a full line of professional dental products. Water Pik’s replacement showerhead business leverages its technology across a broad array of platforms, including EcoFlow (water conservation) and EasySelect (adjustable in-handle water pressure and spray
UK targeted mergers and acquisitions saw 485 deals valued at GBP40.6bn in the first half of 2013, down 16.5 per cent and 10.9 per cent by volume and value, respectively, from H1 2012 when they were 581 deals valued at GBP45.6bn, according to data released by MergerMarket.
A decline in deal value from Q1 to Q2 was responsible for the overall H1 drop. Q2 deals valued at GBP15.1bn were 40.6 per cent down from Q1 2013 (GBP25.5bn) and 46.7 per cent down from Q2 2012 (GBP28.4bn).
The UK however, became more active in the search for companies outside
MPM Capital, a life science-dedicated venture investment firm, has acquired a minority stake in InformedDNA, the largest independent US provider of genetic counselling and genetic benefits management services.
The investment from MPM’s SunStates Fund will be used to expand InformedDNA’s current genetic benefits utilisation management offerings while also funding the development of new specialty genetic services for the pharmaceutical industry.
"InformedDNA’s genetics expertise combined with MPM’s strong track record in biotechnology, specialty pharmaceutical and medical technology investment made this the perfect match," says InformedDNA chief executive officer David Nixon.
InformedDNA’s flagship enterprise is its national network of
Edmond de Rothschild Investment Partners has made the third investment of BioDiscovery 4, its fourth fund dedicated to life sciences, through its participation in the series B financing round of OncoEthix.
OncoEthix is a Swiss-based oncology drug development company founded in 2009. Edmond de Rothschild Investment Partners participated in the Series B financing round of CHF18m alongside SV Life Sciences and existing investors Index Ventures and Endeavour Vision.
The funds will be used for the clinical development of OTX015, a small molecule inhibitor targeting BET bromodomain proteins 2/3/4. The BET proteins are considered potential cancer targets because of
Private equity firm Metric Capital Partners (MCP) has completed its investment in Change of Scandinavia, a leading player in the Nordic lingerie and apparel segment.
Headquartered in Farum, Denmark, Change has a strong focus on comfort, value for money, in-store service levels and large product offering with over 100 custom sizes.
The company was established in 1995 by Claus Jensen, its current chief executive and lead shareholder. Following the opening of its first concept store in Copenhagen in 2001, Change has since enjoyed a strong and steady growth path.
Change benefits from a vertically integrated value chain
Madison Dearborn Partners has agreed to buy Multi Packaging Solutions (MPS), a supplier of print-based specialty packaging, from Irving Place Capital.
Terms of the transaction have not been disclosed.
Multi Packaging Solutions is a manufacturer of high-quality printed folding cartons, labels, and inserts for customers in the healthcare, consumer, and media end markets. MPS has experienced significant growth since Irving Place Capital’s initial investment and now operates 16 manufacturing facilities in the US and Europe, with approximately 2,600 employees worldwide.
“In 2005 we backed entrepreneur Marc Shore with the shared vision of creating a packaging company that
Findis, a French specialist in the wholesale distribution of electrical appliances and kitchen supplies, has acquired Ronzier, a Bordeaux-based wholesaler of electrical appliance and audiovisual products.
Managed by Jean-Christophe Nicodème, Ronzier is based in the Southwest of France. It had a turnover of EUR15m in 2012 and employs 28 people.
Frédéric Jumentier (pictured), president of Findis, says: "Ronzier and Findis have similar vision; we have found in Ronzier’s team the same passion for our profession and the same enthusiasm. With this acquisition, Findis continues its uninterrupted growth for years, based on a distribution model with high added-value, focused
OncoEthix, the Swiss-based specialist in oncology drug development, has closed a series B financing raising CHF18m (USD19m). SV Life Sciences (SVLS) led the financing, joined by new investor Edmond de Rothschild Investment Partners.
Existing investors including Index Ventures and Endeavour Vision also participated in the round.
The proceeds will be used to progress OncoEthix’ novel BET bromodomain inhibitor, OTX015, into Phase II proof of concept studies.
OTX015 is an orally administered synthetic small molecule which targets BET bromodomain proteins 2/3/4. The BET proteins are considered potential cancer targets because of their pivotal role in regulating the transcription of growth-promoting
Shazam has raised USD40m from America Movil, the largest wireless carrier in the Americas, and has formalised a strategic business collaboration between the companies for the Americas.
The investment will help accelerate Shazam’s ongoing growth in music, continued expansion into television and the development of innovative new products.
“Shazam is defining a new category of media engagement which combines the power of mobile with traditional broadcast media and advertising to create compelling value added experiences for consumers, content providers and brands,” says Carlos Slim, owner of America Movil. “We are excited to bring this innovation to America Movil
MEIF4 AX Holdings SAS, a subsidiary of Macquarie European Infrastructure Fund 4, which is managed by Macquarie Infrastructure and Real Assets, has made a friendly takeover offer for Theolia.
Theolia is an independent wind electricity producer, which operates 1,269 MW of wind capacity on its own account and for third party customers in France, Germany, Italy and Morocco.
The offer aims to give Theolia a long-term, majority shareholder that will provide stability in a difficult economic and regulatory environment. Theolia will thus be able to plan for repayment of its convertible bonds ahead of the early redemption date of 1
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
